PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • So why is Teva so worried about paclitaxel? (Of course, I do not know the science, maybe there is a problem that showed up.)I see that the new trial will examine the pharmacokinetics of 011 with not only paclitaxel but also carboplatin.
http://www.w3.org/ns/prov#wasQuotedFrom
  • yahoo.com